港股異動丨東風集團(0489.HK)午後拉漲至6.31% 多家大行看好
格隆匯8月4日丨東風集團(0489.HK)午後拉漲至6.31%,暫報5.9港元,總市值508.4億港元。大和發研報指,近日東風集團(0489.HK)公佈擬於A股上市的計劃,以進一步發展內燃引擎汽車(ICE)及新能源汽車(NEV)方面的技術,該行相信,技術發展是公司重要的一環,相對於H股配股,選擇A股上市是較佳集資選項,維持目標價5.9港元,並重申“優於大市”評級。中銀國際發表報告,按對東風集團今年盈利預測,現時估值相當預測今年市盈率4.6倍,公司考慮在A股及H股作雙重上市,認為市場可能會上述消息產生積極的反應。維持對其“持有”評級,目標價5.5港元,相當於預測今年市盈率5倍。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.